{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-073983","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2026-07-01T11:16:22+00:00","discovered_at":"2026-07-01T11:20:00.260609+00:00","generated_at":"2026-07-01T11:20:06.803746+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"INmune Bio enters warrant inducement; reduces exercise price to $1.40, extends maturity to Dec 2027","bullets":["Holders exercise 647,112 warrants at reduced price of $1.40/share (from $1.95), generating $905,957 in cash.","Remaining 50% of April 2024 warrants have maturity extended from June 30, 2026 to December 31, 2027.","Warrant exercise and amendment executed via Inducement Letter and Second Amendment on June 30, 2026.","Shares underlying warrants are registered under effective registration statement (File No. 333-279036)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-073983","json":"https://secwatch.observer/filing/0001213900-26-073983.json","markdown":"https://secwatch.observer/filing/0001213900-26-073983.md","text":"https://secwatch.observer/filing/0001213900-26-073983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/0001213900-26-073983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/ea0296624-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T11:20:06.803746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}